A model for success

We are led by a team of passionate and respected experts with proven track records of success in drug discovery and commercialization. Their knowledge and experience help foster and inspire innovation at every level of the company. Learn more about what makes us unique.

Our Board of Directors includes the executive leadership of Sumitomo Dainippon Pharma Co., Ltd.

Patricia S. Andrews

Chief Executive Officer
Global Head of Oncology

David J. Bearss, Ph.D.

Chief Scientific Officer
Global Head of Research

Edgar Braendle, M.D., Ph.D.

Chief Medical Officer
Global Head of Development

Dee Mahoney

Senior Vice President
Chief Commercial Officer

Masashi Murata, Ph.D.

Chief Strategy Officer
Global Strategy and Planning

Mark Westgate

Senior Vice President
Chief Financial Officer